Martin Wartenberg
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Co-authors
- Eva Karamitopoulou (8 shared papers)Inti Zlobec (7 shared papers)Beat Gloor (5 shared papers)Aurel Perren (6 shared papers)Erik Vassella (3 shared papers)Mathias Worni (2 shared papers)Alessandro Lugli (5 shared papers)Serenella Eppenberger‐Castori (1 shared paper)
- Journals
- Histopathology (2 papers)Oncogene (2 papers)Cancer Research (2 papers)European Journal of Cancer (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- SwitzerlandGermanyItaly
In The Last Decade
Martin Wartenberg
27 papers receiving 493 citations
Peers
Comparison fields: 5 of 61
- Oncology 238
- Cancer Research 104
- Otorhinolaryngology 14
- Immunology 71
- Pathology and Forensic Medicine 40
Countries citing papers authored by Martin Wartenberg
This map shows the geographic impact of Martin Wartenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Wartenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Wartenberg more than expected).
Fields of papers citing papers by Martin Wartenberg
This network shows the impact of papers produced by Martin Wartenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Wartenberg. The network helps show where Martin Wartenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Wartenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 145 | |
| 2 | 2015 | 54 | |
| 3 | 2021 | 46 | |
| 4 | 2016 | 44 | |
| 5 | 2017 | 36 | |
| 6 | 2018 | 34 | |
| 7 | 2024 | 31 | |
| 8 | 2013 | 27 | |
| 9 | 2016 | 18 | |
| 10 | 2011 | 12 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 6 | |
| 13 | 2020 | 6 | |
| 14 | 2021 | 5 | |
| 15 | 2024 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2021 | 2 | |
| 19 | 2013 | 1 | |
| 20 | 2025 | 1 |
About Martin Wartenberg
Martin Wartenberg is a scholar working on Oncology, Surgery, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 31 papers that have together received 496 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (8 papers), Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Protein Degradation and Inhibitors (2 papers), Antifungal resistance and susceptibility (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Tumors and Oncological Cases (2 papers). The work is most often cited by research in Oncology (238 citations), Cancer Research (104 citations), Otorhinolaryngology (14 citations), Immunology (71 citations) and Pathology and Forensic Medicine (40 citations). Martin Wartenberg has collaborated with scholars based in Switzerland, Germany and Italy. Frequent co-authors include Eva Karamitopoulou, Inti Zlobec, Beat Gloor, Aurel Perren, Erik Vassella, Mathias Worni, Alessandro Lugli, Serenella Eppenberger‐Castori, Micha David Eichmann and Luigi Terracciano. Their work appears in journals such as Histopathology, Oncogene, Cancer Research, European Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.